Vaccine,
Journal Year:
2023,
Volume and Issue:
41(38), P. 5525 - 5534
Published: Aug. 1, 2023
DS-5670a
is
a
vaccine
candidate
for
coronavirus
disease
2019
(COVID-19)
harnessing
novel
modality
composed
of
messenger
ribonucleic
acid
(mRNA)
encoding
the
receptor-binding
domain
(RBD)
from
spike
protein
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
encapsulated
in
lipid
nanoparticles.
Here,
we
report
safety,
immunogenicity,
and
pharmacokinetic
profile
phase
clinical
trial
healthy
adults
who
were
immunologically
naïve
to
SARS-CoV-2.The
study
consisted
an
open-label,
uncontrolled,
dose-escalation
part
double-blind,
randomized,
2-arm,
parallel-group
part.
A
total
80
Japanese
participants
assigned
receive
intramuscular
DS-5670a,
containing
either
30
or
60
µg
mRNA,
as
two
injections
administered
4
weeks
apart.
Safety
was
assessed
by
characterization
treatment-emergent
adverse
events
(TEAEs).
Immunogenicity
neutralization
titers
against
SARS-CoV-2,
anti-RBD
immunoglobulin
(Ig)G
levels,
SARS-CoV-2
spike-specific
T
cell
responses.
Plasma
parameters
also
evaluated.Most
solicited
TEAEs
mild
moderate
with
both
mRNA
doses.
Four
(10
%)
group
developed
redness
at
injection
site,
but
all
cases
resolved
without
treatment.
There
no
serious
leading
discontinuation.
Humoral
immune
responses
dose
groups
greater
than
those
observed
human
convalescent
serum;
produced
better
Neutralization
found
be
correlated
IgG
levels
(specifically
IgG1).
elicited
antigen-specific
helper
1-polarized
cellular
responses.The
mRNA-based
provided
favorable
clinically
acceptable
safety
profile.
Confirmatory
trials
are
currently
ongoing
evaluate
immunogenicity
primary
assess
when
heterologous
homologous
booster.https://jrct.niph.go.jp/latest-detail/jRCT2071210086.
Epidemiology and Infection,
Journal Year:
2023,
Volume and Issue:
151
Published: Jan. 1, 2023
The
COVID-19
pandemic
remains
a
public
health
problem
threatening
national
and
global
security.
socio-economic
impact
of
was
more
severe
on
developing
countries
including
Lebanon,
especially
due
to
the
fragile
healthcare
system,
weak
surveillance
infrastructure
lack
comprehensive
emergency
preparedness
response
plans.
Lebanon
has
been
struggling
with
plethora
challenges
at
social,
economic,
financial,
political
levels
prior
pandemic.
in
revealed
gaps
across
spectrum
emergencies.
Despite
these
challenges,
Lebanese
successful
delaying
steep
surge
cases
hospitalisations
through
imposing
strict
social
measures.
deployment
vaccination
plan
February
2021
coincided
reduction
number
hospitalisation
rates.
aim
this
manuscript
is
advance
epidemiologic
evolution
pre-
post-vaccination,
affecting
recovery,
lessons
learned.
Clinical and Experimental Medicine,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Jan. 27, 2024
Abstract
Over
the
last
24
months,
there
has
been
growing
evidence
of
a
correlation
between
mRNA
COVID-19
vaccine
boosters
and
increased
prevalence
infection
other
pathologies.
Recent
works
have
added
possible
causation
to
correlation.
may
impair
immune
system
response
in
compromised
individuals.
Multiple
doses
vaccines
result
much
higher
levels
IgG
4
antibodies,
or
also
impaired
activation
CD4
+
CD8
T
cells.
The
opportunity
for
needs
careful
consideration,
as
this
impacts
cost-to-benefit
ratio
boosters’
practice.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: May 13, 2024
Abstract
The
safety
and
efficacy
of
COVID-19
vaccines
in
the
elderly,
a
high-risk
group
for
severe
infection,
have
not
been
fully
understood.
To
clarify
these
issues,
this
prospective
study
followed
up
157
elderly
73
young
participants
16
months
compared
safety,
immunogenicity,
two
doses
inactivated
vaccine
BBIBP-CorV
by
booster
dose
recombinant
protein
ZF2001.
results
showed
that
vaccination
protocol
was
safe
tolerable
elderly.
After
administering
BBIBP-CorV,
positivity
rates
titers
neutralizing
anti-RBD
antibodies
were
significantly
lower
than
those
individuals.
ZF2001
dose,
antibody-positive
comparable
to
young;
however,
antibody
remained
lower.
Gender,
age,
underlying
diseases
independently
associated
with
immunogenicity
pseudovirus
neutralization
assay
that,
after
receiving
priming,
some
obtained
immunological
protection
against
BA.5
BF.7
booster.
Breakthrough
infection
symptoms
last
longer
infected
pre-infection
negatively
severity
post-infection
symptoms.
levels
increased
breakthrough
but
still
young.
Our
data
suggest
multiple
vaccinations
at
short
intervals
maintain
high
may
be
an
effective
strategy
protecting
COVID-19.
Frontiers in Bioscience-Landmark,
Journal Year:
2022,
Volume and Issue:
27(2), P. 065 - 065
Published: Feb. 14, 2022
Severe
acute
respiratory
syndrom
coronavirus-2
(SARS
CoV-2)
is
the
causative
agent
of
coronavirus
disease-19
(Covid-19)
which
has
been
designated
a
worldwide
pandemic
by
World
Health
Organization
on
March
11,
2020.
Since
that
time,
virus
mutated
and
an
assortment
variants
have
successful
at
establishing
themselves
in
human
population.
This
review
article
describes
SARS
CoV-2
genome,
hot
spot
mutations,
variants,
then
focuses
Delta
variant,
finishing
up
with
update
Omicron
variant.
The
genome
encompasses
11
open
reading
frames,
one
encodes
spike
or
S
protein
target
for
vaccines
some
drugs
because
its
role
attachment
to
host
cell,
as
well
antibodies.
Mutations
are
common
among
several
include
D614G
increases
transmissibility
viral
load
often
associated
P323L
RNA
dependent
polymerase.
N501Y
mutation
receptor
binding
domain
ACE-2
cells
10
fold.
discussed
carry
combinations
these
other
mutations
classified
concern,
interest,
under
monitoring.
All
characterized
increased
(relative
original
CoV-2),
reason
their
ability
establish
themselves.
Several
but
not
all
more
resistant
antiviral
less
susceptible
antibodies/vaccines.
variant
dominated
world
until
November
2021
causes
risk
hospitalization
death,
still
very
current
vaccines.
most
recent
Omicron,
decreased
antibody
susceptibility.
World Family Medicine Journal/Middle East Journal of Family Medicine,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Jan. 1, 2023
Background:
Sickle
cell
diseases
(SCDs)
are
severe
inflammatory
processes
on
vascular
endothelium,
especially
at
the
capillary
level
because
system
is
actual
distributor
of
hardened
red
blood
cells
(RBCs)
into
tissues.
Methods:
All
cases
with
SCDs
were
included.
Results:
We
studied
222
males
and
212
females
similar
mean
ages
(30.8
vs
30.3
years,
p>0.05,
respectively).
Disseminated
teeth
losses
(5.4%
1.4%,
p<0.001),
ileus
(7.2%
cirrhosis
(8.1%
1.8%,
leg
ulcers
(19.8%
7.0%,
digital
clubbing
(14.8%
6.6%,
coronary
heart
disease
(18.0%
13.2%,
p<0.05),
chronic
renal
(9.9%
6.1%,
obstructive
pulmonary
(25.2%
stroke
(12.1%
7.5%,
p<0.05)
all
higher
in
but
not
acute
chest
syndrome
(2.7%
3.7%),
hypertension
(12.6%
11.7),
deep
venous
thrombosis
and/or
varices
telangiectasias
(9.0%
6.6%),
or
age
mortality
(30.2
33.3
years)
(p>0.05
for
all).
Conclusion:
The
RBCs-induced
endothelial
damage,
inflammation,
edema,
fibrosis
initiated
birth,
terminate
disseminated
tissue
hypoxia
multiorgan
failures
even
childhood
SCDs.
Although
RBCs
supports
corticosteroids
phase
aspirin
plus
hydroxyurea
both
phases
decrease
severity
diseases,
survivals
still
shortened
genders,
dramatically.
Infections,
medical
surgical
emergencies,
emotional
stresses-induced
increased
basal
metabolic
rate
aggravates
sickling
may
painful
crises,
failures,
sudden
deaths.
Key
words:
deaths,
atherosclerosis,
aging
Tropical Medicine and Infectious Disease,
Journal Year:
2023,
Volume and Issue:
8(2), P. 85 - 85
Published: Jan. 26, 2023
There
are
different
area-based
factors
affecting
the
COVID-19
mortality
rate
in
urban
areas.
This
research
aims
to
examine
rates
and
their
geographical
association
with
various
socioeconomic
ecological
determinants
350
of
Tehran’s
neighborhoods
as
a
big
city.
All
deaths
related
included
from
December
2019
July
2021.
Spatial
techniques,
such
Kulldorff’s
SatScan,
geographically
weighted
regression
(GWR),
multi-scale
GWR
(MGWR),
were
used
investigate
spatially
varying
correlations
between
predictors,
including
air
pollutant
factors,
status,
built
environment
public
transportation
infrastructure.
The
city’s
downtown
northern
areas
found
be
significantly
clustered
terms
spatial
temporal
high-risk
for
mortality.
MGWR
model
outperformed
OLS
models
an
adjusted
R2
0.67.
Furthermore,
was
associated
quality
(e.g.,
NO2,
PM10,
O3);
pollution
increased,
so
did
Additionally,
aging
illiteracy
positively
rates.
Our
approach
this
study
could
implemented
potential
associations
other
emerging
infectious
diseases
worldwide.
BMC Medicine,
Journal Year:
2022,
Volume and Issue:
20(1)
Published: Oct. 14, 2022
Abstract
Background
In
view
of
accumulating
case
reports
thyroid
dysfunction
following
COVID-19
vaccination,
we
evaluated
the
risks
incident
inactivated
(CoronaVac)
and
mRNA
(BNT162b2)
vaccines
using
a
population-based
dataset.
Methods
We
identified
people
who
received
vaccination
between
23
February
30
September
2021
from
electronic
health
database
in
Hong
Kong,
linked
to
records.
Thyroid
encompassed
anti-thyroid
drug
(ATD)/levothyroxine
(LT4)
initiation,
biochemical
picture
hyperthyroidism/hypothyroidism,
Graves’
disease
(GD),
thyroiditis.
A
self-controlled
series
design
was
used
estimate
incidence
rate
ratio
(IRR)
56-day
post-vaccination
period
compared
baseline
(non-exposure
period)
conditional
Poisson
regression.
Results
total
2,288,239
at
least
one
dose
(57.8%
BNT162b2
recipients
42.2%
CoronaVac
recipients).
94.3%
92.2%
second
dose.
Following
first
there
no
increase
ATD
initiation
(BNT162b2:
IRR
0.864,
95%
CI
0.670–1.114;
CoronaVac:
0.707,
0.549–0.912),
LT4
0.911,
0.716–1.159;
0.778,
0.618–0.981),
hyperthyroidism
0.872,
0.744–1.023;
0.830,
0.713–0.967)
or
hypothyroidism
1.002,
0.838–1.199;
0.963,
0.807–1.149),
GD,
Similarly,
0.972,
0.770–1.227;
0.879,
95%CI
0.693–1.116),
1.019,
0.833–1.246;
0.768,
0.613–0.962),
1.039,
0.899–1.201;
0.786–1.055),
0.935,
0.794–1.102;
0.945,
0.799–1.119),
Age-
sex-specific
subgroup
sensitivity
analyses
showed
consistent
neutral
associations
both
types
vaccines.
Conclusions
Our
study
evidence
vaccine-related
with
CoronaVac.
Frontiers in Pediatrics,
Journal Year:
2022,
Volume and Issue:
10
Published: Nov. 24, 2022
The
acceptance
of
vaccination
against
COVID-19
among
parents
young
children
plays
a
significant
role
in
controlling
the
current
pandemic.
A
wide
range
factors
that
influence
vaccine
hesitancy
adults
has
been
reported
worldwide,
but
less
attention
given
to
children.
Vaccine
is
considered
major
challenge
achieving
herd
immunity,
and
it
more
challenging
as
they
remain
deeply
concerned
about
their
child's
health.
In
this
context,
systematic
review
literature
inevitable
assess
ensure
successful
ongoing
program.